Horizon Flexible Income ETF (FLXN)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 25, 2025 | $0.15 | 2025-08-22 | 2025-08-22 |
Dividends Summary
- Horizon Flexible Income ETF has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 26 days ago, on August 25, 2025
- The highest dividend payed out to investors during this period was $0.145849 per share
- The average dividend paid during this period was $0.15 per share.
Company News
Pacira's (PCRX) earnings beat estimates in the third quarter of 2021 while revenues miss the same. Its flagship product Exparel's sales rise year over year.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ: AZN) (announced positive data for COVID-19 antibody treatment) Bicycle Therapeutics plc (NASDAQ: BCYC) Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) Itamar Medical Ltd. (NASDAQ: ITMR) Legend Biotech Corporation (NASDAQ: LEGN) Merus N.V. (NASDAQ: MRUS) Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 12) Absci Corporation (NASDAQ: ABSI) Acutus Medical, Inc. (NASDAQ: AFIB) Addex Therapeutics Ltd (NASDAQ: ADXN) ADMA Biologics, Inc. (NASDAQ: ADMA) Allogene Therapeutics, Inc. (NASDAQ: ALLO) Ambrx Biopharma Inc. (NYSE: AMAM) Amgen Inc. (NASDAQ: AMGN) Applied Genetic Technologies Corporation (NASDAQ: AGTC) Applied Molecular Transport Inc. (NASDAQ: AMTI) Athenex, Inc. (NASDAQ: ATNX) (provided positive update from Type A meeting with the Food and Drug Administration regarding approval of breast cancer drug) Axcella Health Inc. (NASDAQ: AXLA) Aytu Biopharma, Inc. (NASDAQ: AYTU) BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) BioSig Technologies, Inc. (NASDAQ: BSGM) BioVie Inc. (NASDAQ: BIVI) Cardiovascular Systems, Inc. (NASDAQ: CSII) Centessa Pharmaceuticals Limited (NASDAQ: CNTA) Century Therapeutics, Inc. (NASDAQ: IPSC) Chemomab Therapeutics Ltd. (NASDAQ: CMMB) DICE Therapeutics, Inc. (NASDAQ: DICE) Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) Eliem Therapeutics, Inc. (NASDAQ: ELYM) Exscientia Holdings Limited (NASDAQ: EXAI) (IPOed Oct. 1) Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) Frequency Therapeutics, Inc. (NASDAQ: FREQ) Gain Therapeutics, Inc. (NASDAQ: GANX) GBS Inc. (NASDAQ: GBS) Glaukos Corporation (NYSE: GKOS) Guardion Health Sciences, Inc. (NASDAQ: GHSI) Harpoon Therapeutics, Inc. (NASDAQ: HARP) HOOKIPA Pharma Inc. (NASDAQ: HOOK) IN8bio, Inc. (NASDAQ: INAB) IsoPlexis Corporation (NASDAQ: ISO) (IPOed Friday) Jasper Therapeutics, Inc. (NASDAQ: JSPR) Kala Pharmaceuticals, Inc. (NASDAQ: KALA) Kamada Ltd. (NASDAQ: KMDA) Kiromic BioPharma, Inc. (NASDAQ: KRBP) (announced strategic collaboration to advance its first allogeneic CAR-T clinical trial candidate, Alexis ISO-1) Kronos Bio, Inc. (NASDAQ: KRON) Mustang Bio, Inc. (NASDAQ: MBIO) Nautilus Biotechnology, Inc. (NASDAQ: NAUT) NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Omeros Corporation (NASDAQ: OMER) OncoSec Medical Incorporated (NASDAQ: ONCS) Orchard Therapeutics plc (NASDAQ: ORTX) Pacira BioSciences, Inc. (NASDAQ: PCRX) - announced deal to acquire Flexion Therapeutics, Inc. (NASDAQ: FLXN) to expand non-opioid pain drug portfolio Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) Pharming Group N.V. (NASDAQ: PHAR) Poseida Therapeutics, Inc. (NASDAQ: PSTX) Prelude Therapeutics Incorporated (NASDAQ: PRLD) Pulmatrix, Inc. (NASDAQ: PULM) Pyxis Oncology, Inc. (NASDAQ: PYXS) (IPOed Friday) Rain Therapeutics Inc. (NASDAQ: RAIN) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) Repare Therapeutics Inc. (NASDAQ: RPTX) Rhythm Pharmaceuticals, Inc. (NASDAQ:
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain pathway --
FLXN earnings call for the period ending December 31, 2020.